Absorbent article having a skin care composition
Abstract
Using 0, 5% by weight to 10% by weight of at least one rheological agent selected from the group consisting of fumed silicas, untreated silicas treated pyrolysis, organoclays in a composition for skin care disposed in at least a portion of a surface in contact with the skin of an absorbent article, so that the composition is at least partially transferable to skin when the article is placed adjacent the skin, the composition also comprises 5 to 95% by weight of a vehicle selected from the group consisting of petroleum-based emollients, polysiloxanes, sucrose ester fatty acids, alkyl ethoxylates, lanolin and mixtures thereof; and 0 001 to 70% by weight of at least one ingredient for skin care selected from the group consisting of allantoin, gel aluminum hydroxide, calamine, cocoa butter, cod-liver oil, glycerine, kaolin , shark liver oil, talc, topical starch, zinc acetate, zinc carbonate, zinc oxide, cell-derived live yeast, aldioxa, aluminum acetate, microporous cellulose, cholecalciferol, colloidal oatmeal, cysteine hydrochloride, dexpanthenol, balsam of Peru, protein hydrolysates, racemic methionine, sodium bicarbonate, Vitamin A, enzyme inhibitors, protease inhibitors, chelating agents, antimicrobial agents proton donors, aloe extracts, allantoin, hexamidine and its salts and derivatives, diisethionate hexamidine and its salts, triacetin, phytic acid, ethylenediaminetetraacetic acid (EDTA), 4- (2- aminoethyl) -bencenesulfonilflururo, chitosan and mixtures thereof, wherein the composition has: (i) an elastic modulus of the least 0, 5 Pa measured at a strain rate of 0, 2%, an oscillation frequency of 10 rad / sec and a temperature of 77 ° C; (Ii) a melting temperature of at least 35 ° C; and (iii) a solid or semisolid consistency at 20 ° C.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
26 members in 13 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 31669199 | United States of America | A | |
| 56363800 | United States of America | A | |
| 0013849 | United States of America | W |
Members26
| Document | Office | Kind | |
|---|---|---|---|
| CA2373570A1 | Canada | A1 | |
| WO0071177A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4858300A | Australia | A | |
| PE20001477A1 | Peru | A1 | |
| EP1178844A1 | European Patent Office (EPO) | A1 | |
| TW476639B | Taiwan Province of China | B | |
| MXPA01011794A | Mexico | A | |
| AR024553A1 | Argentina | A1 | |
| US2002165508A1 | United States of America | A1 | |
| JP2003500115A | Japan | A | |
| US6570054B1 | United States of America | B1 | |
| US2003195486A1 | United States of America | A1 | |
| US6793930B2 | United States of America | B2 | |
| US2004208984A1 | United States of America | A1 | |
| EP1178844B1 | European Patent Office (EPO) | B1 | |
| AT307619TThis record | Austria | T | |
| ATE307619T1 | Austria | T1 | |
| DE60023485D1 | Germany | D1 | |
| US7033645B2 | United States of America | B2 | |
| ES2251376T3 | Spain | T3 | |
| DE60023485T2 | Germany | T2 | |
| CA2373570C | Canada | C | |
| US2009162446A1 | United States of America | A1 | |
| JP4637371B2 | Japan | B2 | |
| US8044256B2 | United States of America | B2 | |
| US2012237683A1 | United States of America | A1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 930827
Titles2
- German
- SAUGFÄHIGER ARTIKEL MIT EINEM KÖRPERPFLEGEMITTEL
- English
- VACCINATED ARTICLE WITH A BODY CARE
Classification
- CPC, 4
- A61L15/34
- A61L15/18
- A61L15/26
- A61L15/48
- IPC, 8
- A61F13 15
- A61F13 472
- A61F13 49
- A61F5 44
- A61L15 18
- A61L15 26
- A61L15 34
- A61L15 48